Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Conversational Agent To Support Follow-up Care For Individuals In Recovery For Substance Use Disorder

NCT06845878 is registered in ClinicalTrials.gov with Dimagi Inc. as lead sponsor.

NCT NCT06845878
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06845878 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Conversational Agent To Support Follow-up Care For Individuals In Recovery For Substance Use Disorder
Lead sponsor
Dimagi Inc.
Phase
Phase 1/2
Overall status
Completed
Start date
March 7, 2025
Completion date
July 22, 2026
Enrollment
55 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opiate substitution treatment, opiate-related disorders